---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-018990"
form_type: "8-K"
ticker: "PLX"
cik: "0001006281"
company_name: "Protalix BioTherapeutics, Inc."
filed_at: "2022-12-27T23:59:59+00:00"
generated_at: "2026-06-20T22:40:42.293223+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Protalix BioTherapeutics sets March 22, 2023 for TASE delisting; will remain on NYSE American

## Summary
- Delisting from Tel Aviv Stock Exchange effective March 22, 2023; last trading day March 20, 2023.
- Common stock will continue to be listed and trade on NYSE American under symbol PLX.
- Israeli shareholders urged to contact their brokers to transfer shares to a NYSE American-based account.

## SEC filing metadata
- accession: 0001558370-22-018990
- form_type: 8-K
- ticker: PLX
- cik: 0001006281
- company_name: Protalix BioTherapeutics, Inc.
- filed_at: 2022-12-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006281/000155837022018990/0001558370-22-018990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006281/000155837022018990/plx-20221227x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-018990
- JSON: https://secwatch.observer/filing/0001558370-22-018990.json
- Plain text: https://secwatch.observer/filing/0001558370-22-018990.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.